Justin Levisay to Pharmacogenomic Variants
This is a "connection" page, showing publications Justin Levisay has written about Pharmacogenomic Variants.
Connection Strength
0.047
-
Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study. Cardiovasc Drugs Ther. 2024 Jun; 38(3):447-457.
Score: 0.047